Hemostasis in vessels of the umbilical cord in premature and extremely premature newborns
DOI:
https://doi.org/10.15574/HW.2023.167.35Keywords:
preterm labour, haemostasis in the umbilical cord vessels, haemostasis in labouring womenAbstract
According to the WHO, about 10% of children are born prematurely every year. The hemostatic system of the fetus and newborn is markedly different from the ones of adults. Physiological concentrations of coagulation proteins gradually increase during pregnancy and are expected lower in preterm infants compared to full-term infants. It’s known today that neonates have a reduction of coagulation factors I-XII (except VIII), the coagulation inhibitors antithrombin III, protein C, and heparin cofactor II at the same time. The tendency to hypocoagulation is more pronounced in premature newborns.
Purpose - to compare the main parameters of hemostasis in full-term and premature newborns in different gestational periods.
Materials and methods. This study has analyzed the level of fibrinogen, D-dimer, prothrombin index, and activated partial thromboplastin time in the blood of mothers and their newborns. The study included three groups of mothers and their newborns: the Group I at 37-41 weeks of gestation, the Group II - 28-34 weeks, the Group III - 22-27 weeks.
Results. The studies have shown that the level of fibrinogen in umbilical cord blood is much lower than in maternal, both in fulltime delivery and in preterm cases of 28-34 weeks and 22-27 weeks. The increase of the D-dimer range comparatively to mother’s is received in all terms and more than double in 22-27 weeks (910±347.6 μg/l in newborn against maternal 487±267.0 μg/l, p<0.05). A fetal prothrombin index level was one and a half more two times smaller in comparison to mothers signs in all cases: 56±9.8% in 35-41 weeks, 53±13.2% in 28-34 weeks and 60±11.7% in 22-27 weeks of gestations. And vice versa, an activated partial thromboplastin time is one and a half more two times higher than all maternal values - 49.7±7.86 sec., 59.4±19.11 sec., and 50.1±22.15 sec. in accordance with terms of gestations with a normal 28-40 sec. in adult.
Conclusions. The blood of newborns in all terms is characterized by a higher level of D-dimer compared to maternal values (970±430.9 μg/l in the term 37-41 weeks, 875±226.1 μg/l in 28-34 weeks, 910±347.6 μg/l in 22-27 weeks). D-dimer concentration ranges in neonates differ from those in adults, so caution is required in their use and interpretation. A higher level of AChT (49.7±7.86 sec; 59.4±19.11 sec; 50.1±22.15 sec, according to groups) and lower fibrinogen values (1840±660.5 mg/l in term 37-41 weeks; 1734±542.6 mg/l in 28-34 weeks; 1498±1005.5 mg/l in 22-27 weeks) and PI (56±9.8%; 53±13.2%; 60±11.7%) compared to their mothers. 2. The level of fibrinogen concentration of full-term newborns (1840±660.5 mg/l) is probably higher, compared to 1498±1005.5 mg/l in the period of 22-27 weeks of gestation (p<0.05), the difference in other indicators of coagulation independently from the gestational age was not statistically significant.
The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the participating institution. The informed consent of the patient was obtained for conducting the studies.
No conflict of interests was declared by the authors.
References
Alarcón P, Werner E, Christensen R. (Eds.). (2013). Neonatal Hematology: Pathogenesis, Diagnosis, and Management of Hematologic Problems (2nd ed.). Cambridge: Cambridge University Press. https://doi.org/10.1017/CBO9780511978135
Amelio GS, Provitera L, Raffaeli G, Tripodi M, Amodeo I, Gulden S et al. (2022). Endothelial dysfunction in preterm infants: The hidden legacy of uteroplacental pathologies. Front Pediatr. 4 (10): 1041919. https://doi.org/10.3389/fped.2022.1041919; PMid:36405831 PMCid:PMC9671930
Catov JM, Bodnar LM, Hackney D, Roberts JM, Simhan HN. (2008). Activation of the fibrinolytic cascade early in pregnancy among women with spontaneous preterm birth. Obstet Gynecol. 112 (5): 1116-1122. https://doi.org/10.1097/AOG.0b013e31818aa5b5; PMid:18978114 PMCid:PMC2731479
Chapin JC, Hajjar KA. (2015). Fibrinolysis and the control of blood coagulation. Blood Rev. 29 (1): 17-24. https://doi.org/10.1016/j.blre.2014.09.003; PMid:25294122 PMCid:PMC4314363
Chawanpaiboon S, Vogel JP, Moller AB, Lumbiganon P, Petzold M, Hogan D et al. (2019). Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modeling analysis. Lancet Glob Health. 7 (1): e37-e46. https://doi.org/10.1016/S2214-109X(18)30451-0; PMid:30389451
De Pablo-Moreno JA, Serrano LJ, Revuelta L, Sánchez MJ, Liras A. (2022). The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V. Int J Mol Sci. 23 (15): 8283. https://doi.org/10.3390/ijms23158283; PMid:35955419 PMCid:PMC9425441
Feller T, Connell SDA, Ariёns RAS. (2022). Why fibrin biomechanical properties matter for hemostasis and thrombosis. J Thromb Haemost. 20 (1): 6-16. https://doi.org/10.1111/jth.15531; PMid:34528378
Haidl H, Zöhrer E, Pohl S, Leschnik B, Weiss EC, Gallistl S, Muntean W, Schlagenhauf A. (2019). New insights into neonatal coagulation: normal clot formation despite lower intra-clot thrombin levels. Pediatr Res. 86 (6): 719-724. https://doi.org/10.1038/s41390-019-0531-4; PMid:31404918
Hochart A, Pierache A, Jeanpierre E, Laffargue A, Susen S, Goudemand J. (2021). Coagulation standards in healthy newborns and infants. Arch Pediatr. 28 (2): 156-158. https://doi.org/10.1016/j.arcped.2020.10.007; PMid:33277135
Hrubaru I, Motoc A, Dumitru C, Bratosin F, Fericean RM, Alambaram S et al. (2023). Assessing the Utility of Hemoglobin, HALP Score, FAR Ratio, and Coagulation Parameters as Predictors for Preterm Birth. Children (Basel). 10 (3): 527. https://doi.org/10.3390/children10030527; PMid:36980085 PMCid:PMC10047754
Hudson NE. (2017). Biophysical Mechanisms Mediating Fibrin Fiber Lysis. Biomed Res Int: 2748340. https://doi.org/10.1155/2017/2748340; PMid:28630861 PMCid:PMC5467299
Katsaras GΝ, Sokou R, Tsantes AG, Piovani D, Bonovas S, Konstantinidi A et al. (2021). The use of thromboelastography (TEG) and rotational thromboelastometry (ROTEM) in neonates: a systematic review. Eur J Pediatr. 180 (12): 3455-3470. https://doi.org/10.1007/s00431-021-04154-4; PMid:34131816
Khalilov Zİ, Ünsal A, Altuntaş N. (2022). The D-dimer reference intervals in healty term newborns. Transfus Apher Sci. 61 (6): 103493. https://doi.org/10.1016/j.transci.2022.103493; PMid:35810118
Kornacki J, Gutaj P, Kalantarova A, Sibiak R, Jankowski M, Wender-Ozegowska E. (2021). Endothelial Dysfunction in Pregnancy Complications. Biomedicines. 9 (12): 1756. https://doi.org/10.3390/biomedicines9121756; PMid:34944571 PMCid:PMC8698592
Monagle P, Massicotte P. (2011). Developmental haemostasis: secondary haemostasis. Semin Fetal Neonatal Med. 16 (6): 294-300. https://doi.org/10.1016/j.siny.2011.07.007; PMid:21872543
Neary E, McCallion N, Kevane B, Cotter M, Egan K, Regan I et al. (2015). Coagulation indices in very preterm infants from cord blood and postnatal samples. J Thromb Haemost. 13 (11): 2021-2030. https://doi.org/10.1111/jth.13130; PMid:26334448
Neary E, Okafor I, Al-Awaysheh F, Kirkham C, Sheehan K, Mooney C et al. (2013). Laboratory coagulation parameters in extremely premature infants born earlier than 27 gestational weeks upon admission to a neonatal intensive care unit. Neonatology. 104 (3): 222-227. https://doi.org/10.1159/000353366; PMid:24030102
Perin J, Mulick A, Yeung D, Villavicencio F, Lopez G, Strong KL et al. (2022). Global, regional, and national causes of under-5 mortality in 2000-19: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet Child Adolesc Health. 6 (2): 106-115. https://doi.org/10.1016/S2352-4642(21)00311-4; PMid:34800370
Punzalan RC, Flood VH. (2012). The Hemostatic System in the Neonate. Textbook of Clinical Pediatrics. In: Elzouki AY, Harfi HA, Nazer HM, Stapleton FB, Oh W, Whitley RJ (eds). Springer: Berlin, Heidelberg: 3101-3113. https://doi.org/10.1007/978-3-642-02202-9_334
Rey Y Formoso V, Barreto Mota R, Soares H. (2022). Developmental hemostasis in the neonatal period. World J Pediatr. 18 (1): 7-15. https://doi.org/10.1007/s12519-021-00492-3; PMid:34981411
Siennicka A, Kłysz M, Chełstowski K, Tabaczniuk A, Marcinowska Z, Tarnowska P et al. (2020). Reference Values of D-Dimers and Fibrinogen in the Course of Physiological Pregnancy: the Potential Impact of Selected Risk Factors-A Pilot Study. Biomed Res Int: 3192350. https://doi.org/10.1155/2020/3192350; PMid:32596295 PMCid:PMC7273490
Sokou R, Foudoulaki-Paparizos L, Lytras T, Konstantinidi Ai, Theodoraki M, Lambadaridis I et al. (2016). Reference ranges of thromboelastometry in healthy full-term and pre-term neonates. Clin Chem Lab Med. 55 (10): 1592-1597. https://doi.org/10.1515/cclm-2016-0931; PMid:28306521
Strauss T, Sidlik-Muskatel R, Kenet G. (2011). Developmental hemostasis: primary hemostasis and evaluation of platelet function in neonates. Semin Fetal Neonatal Med. 16 (6): 301-304. https://doi.org/10.1016/j.siny.2011.07.001; PMid:21810548
World Health Organization (WHO). (2021). Newborns: improving survival and well-being. URL: https://www.who.int/news-room/fact-sheets/detail/newborns-reducing-mortality.
World Health Organization (WHO). (2023). Preterm birth. URL: http://www.who.int/news-room/fact-sheets/detail/preterm-birth.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Ukrainian Journal Health of Woman
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal UKRAINIAN JOURNAL «HEALTH OF WOMAN» is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal UKRAINIAN JOURNAL «HEALTH OF WOMAN» when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.